Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 90 bottles, Rx Only, Manufactured for Acco...

FDA Recall #D-0397-2025 — Class II — April 10, 2025

Recall #D-0397-2025 Date: April 10, 2025 Classification: Class II Status: Ongoing

Product Description

Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 90 bottles, Rx Only, Manufactured for Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, INDIA, NDC 16729-452-15

Reason for Recall

Subpotent

Recalling Firm

ACCORD HEALTHCARE, INC. — Raleigh, NC

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

18,984 Bottles

Distribution

Nationwide US.

Code Information

Lot # D2400725, Exp Date: 03/2026

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated